相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Positive neck margin at frozen section analysis is a significant predictor of tumour recurrence and poor survival after pancreatodudenectomy for pancreatic cancer
Stefano Crippa et al.
EJSO (2020)
The value of combined vein resection in pancreaticoduodenectomy for pancreatic head carcinoma: a meta-analysis
Cheng Peng et al.
BMC SURGERY (2019)
Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial
U. A. Wittel et al.
BMC CANCER (2019)
Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study
Nicolo Pecorelli et al.
FRONTIERS IN ONCOLOGY (2019)
Mesenterico-portal vein invasion should be an important factor in TNM staging for pancreatic ductal adenocarcinoma: Proposed modification of the 8th edition of the American Joint Committee on Cancer staging system
Hong-Yu Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Venous resection during pancreatectomy for pancreatic cancer: a systematic review
Xiaobo Wang et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer
E. Versteijne et al.
BRITISH JOURNAL OF SURGERY (2018)
International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017
Shuji Isaji et al.
PANCREATOLOGY (2018)
Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer
Aoi Hayasaki et al.
CANCERS (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications
Giovanni Marchegiani et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
John P. Neoptolemos et al.
LANCET (2017)
The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After
Claudio Bassi et al.
SURGERY (2017)
Preoperative predictors for early recurrence of resectable pancreatic cancer
Kohei Nishio et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2017)
Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic cancer
R. Ravikumar et al.
BRITISH JOURNAL OF SURGERY (2017)
Trends in indications, complications and outcomes for venous resection during pancreatoduodenectomy
D. Kleive et al.
BRITISH JOURNAL OF SURGERY (2017)
Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma
F. Giovinazzo et al.
BRITISH JOURNAL OF SURGERY (2016)
Effect of Hospital Volume on Surgical Outcomes After Pancreaticoduodenectomy: A Systematic Review and Meta-analysis
Tatsuo Hata et al.
ANNALS OF SURGERY (2016)
Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
Cristina R. Ferrone et al.
ANNALS OF SURGERY (2015)
Cattell-Braasch Maneuver Combined with Artery-First Approach for Superior Mesenteric-Portal Vein Resection During Pancreatectomy
Marco Del Chiaro et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2015)
Current State of Vascular Resections in Pancreatic Cancer Surgery
Thilo Hackert et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2015)
Value of Intraoperative Neck Margin Analysis During Whipple for Pancreatic Adenocarcinoma A Multicenter Analysis of 1399 Patients
David A. Kooby et al.
ANNALS OF SURGERY (2014)
Impact of centralization of pancreatic cancer surgery on resection rates and survival
G. A. Gooiker et al.
BRITISH JOURNAL OF SURGERY (2014)
Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: A meta-analysis
X. Z. Yu et al.
EJSO (2014)
Pancreatic Adenocarcinoma
David P. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
Sonja Gillen et al.
PLOS MEDICINE (2010)
Resectable Pancreatic Cancer: Who Really Benefits From Resection?
Giuliano Barugola et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Interposition graft with polytetrafluoroethylene for mesenteric and portal vein reconstruction after pancreaticoduodenectomy
J. A. Stauffer et al.
BRITISH JOURNAL OF SURGERY (2009)
Vascular Resection in Pancreatic Cancer Surgery: Survival Determinants
Sascha A. Mueller et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
Borderline resectable pancreatic cancer: The importance of this emerging stage of disease
Matthew H. G. Katz et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2008)
Redefining the R1 resection in pancreatic cancer
C. S. Verbeke et al.
BRITISH JOURNAL OF SURGERY (2006)
Pancreaticoduodenectomy: Superior mesenteric artery first approach
P Pessaux et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2006)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)
分享论文
